Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 7/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | NR3C1 | P04150 | 6/20 | 0.64 |
| ▸ | PGR | P06401 | 6/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.64 |
| ▸ | AR | P10275 | 2/20 | 0.64 |
| ▸ | TNF | P01375 | 1/20 | 0.64 |
| ▸ | IL6 | P05231 | 1/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.64 |
| ▸ | GLUL | P15104 | 1/20 | 0.64 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.64 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7613014 | 1.00 | NR3C2 (0.74) | NR3C2HIF1AKMT2ANR3C1PGR | |
| SCHEMBL7145314 | 1.00 | NR3C2 (0.74) | NR3C2HIF1AKMT2ANR3C1PGR | |
| SCHEMBL7984 | 0.99 | NR3C2 (0.74) | NR3C2HIF1AKMT2ANR3C1PGR | |
| Prednival SCHEMBL11585728 | 0.98 | HIF1A (0.73) | NR3C2HIF1AKMT2ANR3C1PGR | |
| Prednival SCHEMBL2966209 | 0.98 | HIF1A (0.73) | NR3C2HIF1AKMT2ANR3C1PGR | |
| Prednival SCHEMBL25388 | 0.98 | HIF1A (0.73) | NR3C2HIF1AKMT2ANR3C1PGR | |
| Prednival SCHEMBL2966212 | 0.98 | HIF1A (0.73) | NR3C2HIF1AKMT2ANR3C1PGR | |
| Prednival SCHEMBL25387 | 0.98 | HIF1A (0.73) | NR3C2HIF1AKMT2ANR3C1PGR | |
| SCHEMBL11016342 | 0.94 | NR3C2 (0.72) | NR3C2HIF1AKMT2ANR3C1PGR | |
| SCHEMBL6857090 | 0.94 | NR3C2 (0.72) | NR3C2HIF1AKMT2ANR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0041772-B2 | FAT EMULSION CONTAINING A STEROID | GREEN CROSS CORPORATION (JP) | 1990-04-18 | — | — | EP | claimed |
| EP-0041772-B1 | FAT EMULSION CONTAINING A STEROID | GREEN CROSS CORPORATION (JP) | 1984-10-17 | — | — | EP | claimed |
| US-4340594-A | Fat emulsion containing steroid | THE GREEN CROSS CORPORATION (JP) | 1982-07-20 | — | — | US | claimed |
| EP-0041772-A2 | Fat emulsion containing a steroid | GREEN CROSS CORPORATION (JP) | 1981-12-16 | — | — | EP | claimed |
| EP-0331755-B2 | MEDICINE-CONTAINING FAT EMULSION OF THE TYPE PREPARED IMMEDIATELY BEFORE USE AND PROCESS FOR PREPARING MEDICINE-CONTAINING FAT EMULSION | TEIJIN LTD (JP) | 2003-02-05 | — | — | EP | disclosed |
| EP-0331755-B1 | MEDICINE-CONTAINING FAT EMULSION OF THE TYPE PREPARED IMMEDIATELY BEFORE USE AND PROCESS FOR PREPARING MEDICINE-CONTAINING FAT EMULSION | TEIJIN LIMITED (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-5229422-A | Drug delivery | TEIJIN LIMITED (JP) | 1993-07-20 | — | — | US | disclosed |
| EP-0041772-B2 | FAT EMULSION CONTAINING A STEROID | GREEN CROSS CORPORATION (JP) | 1990-04-18 | — | — | EP | disclosed |
| EP-0331755-A1 | MEDICINE-CONTAINING FAT EMULSION OF THE TYPE PREPARED IMMEDIATELY BEFORE USE AND PROCESS FOR PREPARING MEDICINE-CONTAINING FAT EMULSION | TEIJIN LIMITED (JP) | 1989-09-13 | — | — | EP | disclosed |
| EP-0041772-B1 | FAT EMULSION CONTAINING A STEROID | GREEN CROSS CORPORATION (JP) | 1984-10-17 | — | — | EP | disclosed |
| US-4340594-A | Fat emulsion containing steroid | THE GREEN CROSS CORPORATION (JP) | 1982-07-20 | — | — | US | disclosed |
| EP-0041772-A2 | Fat emulsion containing a steroid | GREEN CROSS CORPORATION (JP) | 1981-12-16 | — | — | EP | disclosed |